10 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller

Page 4 of 4

6. Option Care Health (NASDAQ:OPCH)

Druckenmiller’s Stake: $50,301,000

Option Care Health (NASDAQ:OPCH) provides home and outpatient infusion therapy services. It delivers medications like antibiotics and immune therapies directly to patients outside hospitals.

The stock has long-term potential because an aging population is increasing demand for ongoing treatments that don’t require hospital stays, which supports this shift toward home-based care.

Health systems are trying to reduce costs by moving care out of hospitals, and infusion-at-home services are usually cheaper than inpatient treatment. This would bode well for Option Care Health (NASDAQ:OPCH).

However, sentiment turned more cautious after Bank of America downgraded the stock from Buy to Neutral, following a cut to full-year guidance. The bank pointed to tougher insurance approvals and rising competition from pharmacy benefit managers and integrated pharmacy networks, and also lowered its price target sharply.

While we acknowledge the potential of OPCH to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than OPCH and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see the 5 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller.

Disclosure: None. Follow Insider Monkey on Google News.

Page 4 of 4
1281292 - 11759070 - 1